Skip to main content
Fig. 1 | Molecular Brain

Fig. 1

From: Lysosomal dysfunction in proteinopathic neurodegenerative disorders: possible therapeutic roles of cAMP and zinc

Fig. 1

Schematic depiction of cAMP- and Zn2+-mediated lysosomal acidification. Increases in cAMP levels through activation of adenylyl cyclase and/or inhibition of PDEs activate PKA. PKA activation leads to increases in lysosomal free Zn2+ levels by an as yet unidentified mechanism. Increases in lysosomal Zn2+ levels restore lysosomal acidity through an unknown mechanism, even in the presence of BA, a potent and selective inhibitor of the main proton pump, V-ATPase

Back to article page